Remifentanil: Do we need any other opioid?;Remifentanil: Por que precisamos de outro opióide?

Revista Brasileira de Anestesiologia

Volumn 51, Issue 2, 2001, Pages 146-159

  Nora, F S ^a   Fortis, E A F ^a  

^a NONE   (Brazil)

Author keywords

Analgesics; Opioids: remifentanil

Indexed keywords

ALFENTANIL; DRUG METABOLITE; FENTANYL; OPIATE; PROPOFOL; REMIFENTANIL; SUFENTANIL;

ABDOMINAL SURGERY; ANALGESIA; ANESTHETIC RECOVERY; CONTINUOUS INFUSION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFECT; DRUG HALF LIFE; DRUG METABOLISM; DRUG POTENTIATION; DRUG PROTEIN BINDING; HEART SURGERY; HEMODYNAMICS; HUMAN; MUSCLE RIGIDITY; ORTHOPEDIC SURGERY; PHYSICAL CHEMISTRY; RESPIRATION DEPRESSION; REVIEW; THORAX SURGERY;

EID: 0035095763     PISSN: 00347094     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Ambulatory anesthesia experience with remifentanil
2. Anestesia venosa
3. Total intravenous anesthesia
4. Intravenous drug delivery systems
5. Remifentanil compared with alfentanil for ambulatory surgery using total intravenous anesthesia
6. An overview of remifentanil
7. Educational considerations for the clinical introduction and use of remifentanil
8. A review of the pharmacokinetics and pharmacodynamics of remifentanil
9. Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease
10. Pharmacokinetics and pharmacodynamics of remifentanil in persons with renal failure compared to healthy volunteers
11. Remifentanil is not metabolized by lung
12. Pharmacokinetics of remifentanil in anesthetized children 2-12 years of age
13. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development
14. The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers
15. Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: Remifentanil (GI87084B)
16. Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery
17. A randomized blinded comparison of remifentanil and alfentanil during anesthesia for outpatient surgery
18. Remifentanil: Ultra-short acting opioid for obstetric anesthesia
19. Propofol anesthesia and rational opioid selection-determination of optimal EC50-EC95 propofol-opioid concentrations that assure adequate anesthesia and a rapid return of consciousness
20. Balanced anesthesia
21. Reduction of isoflurane minimal alveolar concentration by remifentanil
22. A model to determine the relative potency of mu opioids: Alfentanil versus remifentanil
23. Inpatient experience with remifentanil
24. Multicenter evaluation of total intravenous anesthesia with remifentanil and propofol for elective inpatient surgery
25. Remifentanil, um opióide metabolizado pela esterase
26. Behavioral and physiological effects of remifentanil and alfentanil in healthy volunteers
27. Remifentanil pharmacokinetics in obese versus lean patients
28. Fentanil and congeners
29. Biphasic respiratory depression after fentanyl - Droperidol or fentanyl alone used to supplement nitrous oxide anaesthesia
30. Acute respiratory arrest and rigidity after anaesthesia with sufentanil: A case report
31. Delayed respiratory depression after alfentanil
32. Quantifying anaesthetic drug interaction. Implications for drug dosing
33. The pharmacodynamic interaction of propofol and alfentanil during lower abdominal surgery in women
34. Novos opióides e opçōes de uso